Parham Jabbarzadeh Kaboli

Author

Also Known As

Bin Wei, Huijiao Ji, Mazaher Maghsoudloo, Parham Jabbarzadeh Kaboli, Parham Jabbarzadeh Kaboli, Parham Kaboli, Qinglian Wen

Publications

Citations

H-Index

Concepts

All Affiliations

Southwest Medical University Affiliated Hospital of Southwest Medical University First Affiliated Hospital of Sichuan Medical University China Medical University Universiti Putra Malaysia

About

Parham Jabbarzadeh Kaboli is an author at Southwest Medical University specializing in tumor biology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	260
2	Engineering	1	1	10
3	Natural Sciences	1	1	34
4	Biochemistry	1	1	34
5	Biomolecular Engineering	1	1	34

Parham Jabbarzadeh Kaboli

Publications

845

Citations

H-Index

Page 1

	Year	Citations
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer Yueshui Zhao, Qijie Zhao, Parham Jabbarzadeh Kaboli, Translational Oncology	2019	209
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma Shixin Xiang, Jing Li, Jing Shen, Frontiers in Immunology	2021	94
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer Yongshun Ma, Yao Zhang, Houxiang Jiang, Frontiers in Cellular and Infection Microbiology	2021	83
Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study Parham Jabbarzadeh Kaboli, Melody Pui-Yee Leong, Patimah Ismail, Pharmacological Reports OncologyMedicineVitro StudyBreast CancerAntitumor Effects	2018	62
CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells Jianhua Yin, Hanyu Zhang, Xu Wu, International Journal of Molecular Medicine ImmunologyCancer BiologyTumor BiologyTumor ImmunityCancer Cell Biology	2020	43
Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy. Parham Jabbarzadeh Kaboli, Saber İmani, Masume Jomhori, PubMed Breast OncologyChemoprevention StrategyAkt SignallingCancer BiologyTumor Biology	2021	38
Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates. Parham Jabbarzadeh Kaboli, Shima Shabani, Sagar Sharma, PubMed Breast OncologyMedicineAntibody-drug ConjugateImmunologyPharmacology	2022	36
Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment Parham Jabbarzadeh Kaboli, Patimah Ismail, King‐Hwa Ling PLoS ONE Bioorganic ChemistryChemoprevention StrategyRaf InhibitorsChemical BiologyPharmaceutical Chemistry	2018	34
m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer Shixin Xiang, Yongshun Ma, Jing Shen, Frontiers in Molecular Biosciences	2020	34
Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions Hannaneh Parvaresh, Ghazaal Roozitalab, Fatemeh Golandam, Biomedicines	2024	33

Page 1